These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 16918293)

  • 1. The use of neck pinhole SPECT in hyperparathyroidism and differentiated thyroid carcinoma.
    Spanu A; Madeddu G
    Cancer Biother Radiopharm; 2006 Jun; 21(3):175-80. PubMed ID: 16918293
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
    Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
    J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc labelled cationic lipophilic complexes in malignant and benign tumors: the role of SPET and pinhole-SPET in breast cancer, differentiated thyroid carcinoma and hyperparathyroidism.
    Spanu A; Schillaci O; Madeddu G
    Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):145-69. PubMed ID: 16010252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical paraganglioma mimicking a parathyroid adenoma on Tc-99m sestamibi scintigraphy.
    Bhattacharya A; Mittal BR; Bhansali A; Radotra BD; Behera A
    Clin Nucl Med; 2006 Apr; 31(4):234-6. PubMed ID: 16550027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallel hole versus pinhole collimator for technetium-99m sestamibi scintigraphy, in the diagnosis of parathyromatosis.
    Koukouraki S; Stathaki M; Stylianou K; Daphnis E; Karkavitsas N
    Hell J Nucl Med; 2007; 10(1):33. PubMed ID: 17450249
    [No Abstract]   [Full Text] [Related]  

  • 6. Preoperative technetium Tc 99m sestamibi SPECT imaging in the management of primary hyperparathyroidism in patients with concomitant multinodular goiter.
    Lorberboym M; Ezri T; Schachter PP
    Arch Surg; 2005 Jul; 140(7):656-60. PubMed ID: 16027330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of imaging studies in the diagnosis and management of thyroid cancer and hyperparathyroidism.
    James C; Starks M; MacGillivray DC; White J
    Surg Oncol Clin N Am; 1999 Jan; 8(1):145-69. PubMed ID: 9824366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism.
    Neumann DR; Obuchowski NA; Difilippo FP
    J Nucl Med; 2008 Dec; 49(12):2012-7. PubMed ID: 18997051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the yield of preoperative parathyroid localization: technetium Tc 99m-sestamibi imaging after thyroid suppression.
    Royal RE; Delpassand ES; Shapiro SE; Fritsche HA; Vassilopoulou-Sellin R; Sherman SI; Gagel RF; Evans DB; Lee JE
    Surgery; 2002 Dec; 132(6):968-74; discussion 974-5. PubMed ID: 12490843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism.
    Neumann DR; Esselstyn CB; Go RT; Wong CO; Rice TW; Obuchowski NA
    AJR Am J Roentgenol; 1997 Dec; 169(6):1671-4. PubMed ID: 9393188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc-SestaMIBI scintigraphy of thyroid gland in a patient with primary hyperparathyroidism: unusual features due to coesistence of a thyroid papillary carcinoma.
    Boi F; Cau R; Piga M; Serra A; Loy M; Lai ML; Mariotti S
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):823-4. PubMed ID: 14974929
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of 99mTc-sestamibi uptake in brown adipose tissue with SPECT-CT.
    Belhocine T; Shastry A; Driedger A; Urbain JL
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):149. PubMed ID: 17021807
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of FDG-PET and technetium-99m MIBI SPECT to detect metastatic cervical lymph nodes in well-differentiated thyroid carcinoma with elevated serum HTG but negative I-131 whole body scan.
    Wu HS; Huang WS; Liu YC; Yen RF; Shen YY; Kao CH
    Anticancer Res; 2003; 23(5b):4235-8. PubMed ID: 14666632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early, postinjection MIBI-SPECT as the only preoperative localizing study for minimally invasive parathyroidectomy.
    Schachter PP; Issa N; Shimonov M; Czerniak A; Lorberboym M
    Arch Surg; 2004 Apr; 139(4):433-7. PubMed ID: 15078713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of calcium channel blockers on the sensitivity of preoperative 99mTc-MIBI SPECT for hyperparathyroidism.
    Friedman K; Somervell H; Patel P; Melton GB; Garrett-Mayer E; Dackiw AP; Civelek AC; Zeiger MA
    Surgery; 2004 Dec; 136(6):1199-204. PubMed ID: 15657576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radionuclide imaging for hyperparathyroidism (HPT): which is the best technetium-99m sestamibi modality?
    Sharma J; Mazzaglia P; Milas M; Berber E; Schuster DM; Halkar R; Siperstein A; Weber CJ
    Surgery; 2006 Dec; 140(6):856-63; discussion 863-5. PubMed ID: 17188131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of scintigraphy with dual tracer and potassium perchlorate (99mTcO4 & KClO4/ MIBI) in primary hyperparathyroidism].
    Rubello D; Saladini G; Casara D
    Minerva Endocrinol; 2001 Mar; 26(1):13-21. PubMed ID: 11323563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of 99mTc-pertechnetate single-photon emission computed tomography in remnant mass estimation of postsurgical patients of differentiated thyroid cancer during internal dosimetry.
    Nadig MR; Pant GS; Bal C
    Nucl Med Commun; 2008 Sep; 29(9):809-14. PubMed ID: 18677209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of SPECT/CT in the preoperative assessment of hyperparathyroid patients.
    Serra A; Bolasco P; Satta L; Nicolosi A; Uccheddu A; Piga M
    Radiol Med; 2006 Oct; 111(7):999-1008. PubMed ID: 17021682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography.
    Neumann DR; Esselstyn CB; Madera A; Wong CO; Lieber M
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3867-71. PubMed ID: 9814460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.